RE:my last two cents on this board"just a simple reason why you spend so much time and effort on something that has no results."
No results? I think you are looking at it all wrong. I think the bashers have gotten to you and that you are missing important context. We've literally been through the worst biotech bear market in history. In recent months 25% of biotech stocks have traded below the value of the cash on the balance sheet. Let that sink in. 25% of biotech companies have been worth less than the cash on the balance sheet. The science has had a negative value. This has been an environment where proving survival and resilience has been important. In this context, CZO has outperformed the S&P Biotech ETF despite small cap biotech being particularily hard hit. CZO has continued to produce record revenue as it builds cash demonstrating resilience. CZO has turned the prototype PGX-OBG into a next-gen product informed by industry and now with the blowout bioavailability data we've seen. PGX may even be able to hijack macrophages creating a Trojan Horse. Amazing! Dr. Ask, now a leading scientist with the second largest pharma in the world, has expressed his excitement about the fibrosis research which is approaching a Phase I decision. The avenanthramide pill is now approved for human trials by Health Canada. Ronnie Miller, the former 22 year President and CEO of the Canadian division of the second largest biotech in the world, has joined CZO's Board of Directors and become Chairman. He has endorsed the building blocks for long term growth that have been assembled. CZO has produced exceptional results; especially for such a small company.